Medicine Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Brand Drugs, Generic Drugs); End User (Hospital, Clinic, Other) and Geography
Report Code: TIPRE00019345 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
A medicine (also referred to as a pharmaceutical drug) is a drug used to diagnose, cure, treat, or prevent disease. Medicine therapy is an integral part of the medical field and relies on pharmacology science for continual advancement and pharmacy for appropriate management.
MARKET DYNAMICS
Factors like the rising prevalence of diseases among the population, increased drug approvals by the regulatory bodies, and the pharmaceutical firms' continuous investments to expand their manufacturing facilities have positively impacted medicine market growth. However, side effects associated with medicine consumption will hamper the market growth.
MARKET SCOPE
The "Medicine Market Analysis to 2028" is a specialized and in-depth study of the Pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of medicine market with detailed market segmentation with type and end user. The medicine market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in medicine market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The medicine market is segmented on the basis of type and end user. On the basis of type, the medicine market is divided into brand drugs and generic drugs. Based on end user, the medicine market can be segmented as hospitals, clinics and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the medicine market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The medicine market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyses factors affecting medicine market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the medicine market in these regions.
The report covers key developments in medicine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from medicine market are anticipated to have lucrative growth opportunities in the future with the rising demand for medicine in the global market. Below mentioned is the list of few companies engaged in the medicine market.
The report also includes the profiles of key players in medicine market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
- GlaxoSmithKline plc
- AstraZeneca plc
- Novartis AG
- Eli Lilly and Company
- Sanofi S.A.
- Allergan, Inc.
- F. Hoffmann-La Roche AG
- Merck and Co., Inc.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Medicine Market - By Type
1.3.2 Medicine Market - By End User
1.3.3 Medicine Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. MEDICINE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.3. EXPERT OPINIONS
5. MEDICINE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. MEDICINE MARKET - GLOBAL MARKET ANALYSIS
6.1. MEDICINE - GLOBAL MARKET OVERVIEW
6.2. MEDICINE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. MEDICINE MARKET - REVENUE AND FORECASTS TO 2028 – TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. BRAND DRUGS
7.3.1. Overview
7.3.2. Brand Drugs Market Forecast and Analysis
7.4. GENERIC DRUGS
7.4.1. Overview
7.4.2. Generic Drugs Market Forecast and Analysis
8. MEDICINE MARKET - REVENUE AND FORECASTS TO 2028 – END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL
8.3.1. Overview
8.3.2. Hospital Market Forecast and Analysis
8.4. CLINIC
8.4.1. Overview
8.4.2. Clinic Market Forecast and Analysis
8.5. OTHER
8.5.1. Overview
8.5.2. Other Market Forecast and Analysis
9. MEDICINE MARKET REVENUE AND FORECASTS TO 2028 – GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Medicine Market Overview
9.1.2 North America Medicine Market Forecasts and Analysis
9.1.3 North America Medicine Market Forecasts and Analysis - By Type
9.1.4 North America Medicine Market Forecasts and Analysis - By End User
9.1.5 North America Medicine Market Forecasts and Analysis - By Countries
9.1.5.1 United States Medicine Market
9.1.5.1.1 United States Medicine Market by Type
9.1.5.1.2 United States Medicine Market by End User
9.1.5.2 Canada Medicine Market
9.1.5.2.1 Canada Medicine Market by Type
9.1.5.2.2 Canada Medicine Market by End User
9.1.5.3 Mexico Medicine Market
9.1.5.3.1 Mexico Medicine Market by Type
9.1.5.3.2 Mexico Medicine Market by End User
9.2. EUROPE
9.2.1 Europe Medicine Market Overview
9.2.2 Europe Medicine Market Forecasts and Analysis
9.2.3 Europe Medicine Market Forecasts and Analysis - By Type
9.2.4 Europe Medicine Market Forecasts and Analysis - By End User
9.2.5 Europe Medicine Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Medicine Market
9.2.5.1.1 Germany Medicine Market by Type
9.2.5.1.2 Germany Medicine Market by End User
9.2.5.2 France Medicine Market
9.2.5.2.1 France Medicine Market by Type
9.2.5.2.2 France Medicine Market by End User
9.2.5.3 Italy Medicine Market
9.2.5.3.1 Italy Medicine Market by Type
9.2.5.3.2 Italy Medicine Market by End User
9.2.5.4 Spain Medicine Market
9.2.5.4.1 Spain Medicine Market by Type
9.2.5.4.2 Spain Medicine Market by End User
9.2.5.5 United Kingdom Medicine Market
9.2.5.5.1 United Kingdom Medicine Market by Type
9.2.5.5.2 United Kingdom Medicine Market by End User
9.2.5.6 Rest of Europe Medicine Market
9.2.5.6.1 Rest of Europe Medicine Market by Type
9.2.5.6.2 Rest of Europe Medicine Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Medicine Market Overview
9.3.2 Asia-Pacific Medicine Market Forecasts and Analysis
9.3.3 Asia-Pacific Medicine Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Medicine Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Medicine Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Medicine Market
9.3.5.1.1 Australia Medicine Market by Type
9.3.5.1.2 Australia Medicine Market by End User
9.3.5.2 China Medicine Market
9.3.5.2.1 China Medicine Market by Type
9.3.5.2.2 China Medicine Market by End User
9.3.5.3 India Medicine Market
9.3.5.3.1 India Medicine Market by Type
9.3.5.3.2 India Medicine Market by End User
9.3.5.4 Japan Medicine Market
9.3.5.4.1 Japan Medicine Market by Type
9.3.5.4.2 Japan Medicine Market by End User
9.3.5.5 South Korea Medicine Market
9.3.5.5.1 South Korea Medicine Market by Type
9.3.5.5.2 South Korea Medicine Market by End User
9.3.5.6 Rest of Asia-Pacific Medicine Market
9.3.5.6.1 Rest of Asia-Pacific Medicine Market by Type
9.3.5.6.2 Rest of Asia-Pacific Medicine Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Medicine Market Overview
9.4.2 Middle East and Africa Medicine Market Forecasts and Analysis
9.4.3 Middle East and Africa Medicine Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Medicine Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Medicine Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Medicine Market
9.4.5.1.1 South Africa Medicine Market by Type
9.4.5.1.2 South Africa Medicine Market by End User
9.4.5.2 Saudi Arabia Medicine Market
9.4.5.2.1 Saudi Arabia Medicine Market by Type
9.4.5.2.2 Saudi Arabia Medicine Market by End User
9.4.5.3 U.A.E Medicine Market
9.4.5.3.1 U.A.E Medicine Market by Type
9.4.5.3.2 U.A.E Medicine Market by End User
9.4.5.4 Rest of Middle East and Africa Medicine Market
9.4.5.4.1 Rest of Middle East and Africa Medicine Market by Type
9.4.5.4.2 Rest of Middle East and Africa Medicine Market by End User
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. MEDICINE MARKET, KEY COMPANY PROFILES
11.1. PFIZER INC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. TEVA PHARMACEUTICAL INDUSTRIES LTD.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. GLAXOSMITHKLINE PLC
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. ASTRAZENECA PLC
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. NOVARTIS AG
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. ELI LILLY AND COMPANY
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. SANOFI S.A.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. ALLERGAN, INC.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. F. HOFFMANN-LA ROCHE AG
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. MERCK AND CO., INC.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1.Pfizer Inc.
2.Teva Pharmaceutical Industries Ltd.
3.GlaxoSmithKline plc
4.AstraZeneca plc
5.Novartis AG
6.Eli Lilly and Company
7.Sanofi S.A.
8.Allergan, Inc.
9.F. Hoffmann-La Roche AG
10.Merck and Co., Inc.
Get the Latest COVID-19 Analysis on this market
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak To Analyst
-
$3000
-
$4550
-
$6550
-
$8550
-
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount